Display options
Share it on

HSS J. 2018 Feb;14(1):67-76. doi: 10.1007/s11420-017-9577-1. Epub 2017 Oct 13.

Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery Patients.

HSS journal : the musculoskeletal journal of Hospital for Special Surgery

Anne R Bass, Jackie D Szymonifka, Matthew T Rondina, Margaret Bogardus, Mitchell G Scott, Scott C Woller, Scott M Stevens, Charles Eby, Kerri Merritt, Alejandro Gonzalez Della Valle, Gerard Moskowitz, Eva Flores, Brian F Gage

Affiliations

  1. 1Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021 USA.
  2. 7Weill Cornell Medicine, New York, NY 10065 USA.
  3. 2The University of Utah, Salt Lake City, UT USA.
  4. 3Columbia University College of Physicians & Surgeons, New York City, NY USA.
  5. 4Washington University School of Medicine, St. Louis, MO USA.
  6. 5Intermountain Healthcare, Murray, UT USA.
  7. 6New York Presbyterian Hospital, New York City, NY USA.

PMID: 29398998 PMCID: PMC5786589 DOI: 10.1007/s11420-017-9577-1

Abstract

BACKGROUND: Orthopedic patients are at risk for adverse postoperative cardiovascular outcomes.

QUESTIONS/PURPOSES: This pilot randomized controlled trial (RCT) of atorvastatin vs. placebo in orthopedic surgery patients was performed in order to assess: (1) the prevalence of perioperative myocardial injury; (2) the effect of atorvastatin on perioperative inflammation; and (3) the feasibility of performing a large RCT of statin therapy in orthopedic patients.

METHODS: Hip fracture (hip Fx) and total hip and knee replacement (THR and TKR) patients were randomized 1:1 to atorvastatin 40 mg daily vs. placebo, starting preoperatively and continuing until postoperative day (POD) 45. High-sensitivity cardiac troponin I (hs-cTnI), high-sensitivity C-reactive protein (hs-CRP), and interleukin-6 (IL-6) were measured preoperatively and on POD 2. Patients were monitored for adverse events until POD 90.

RESULTS: Five hundred fifty-six patients were screened, 22 were recruited (4 hip Fx, 11 THR, 7 TKR), and 2 withdrew. Most (80%) had detectable hs-cTnI (> 1.1 pg/mL) preoperatively. Twenty percent had a perioperative rise in hs-cTnI (≥ 10 pg/mL), which was not blunted by atorvastatin. Hs-CRP rose in 19/20 patients, and IL-6 rose in all patients. However, atorvastatin did not blunt the rise in these inflammatory biomarkers. On POD 2, IL-6 and hs-cTnI levels correlated (

CONCLUSION: Perioperative myocardial injury and inflammation are common in orthopedic patients and do not appear to be reduced in those randomized to atorvastatin.

TRIAL REGISTRATION: NCT02197065.

Keywords: C-reactive protein; inflammation; interleukin-6; myocardial ischemia; orthopedics; troponin

Conflict of interest statement

Compliance with Ethical StandardsJaclyn D. Szymonifka, MA; Matthew T. Rondina, MD, MS; Margaret Bogardus, BA; Scott C. Woller, MD; Scott M. Stevens, MD; Kerri Merritt; Gerard Moskowitz, PhD; Alejandro

References

  1. N Engl J Med. 1995 Nov 16;333(20):1301-7 - PubMed
  2. Int Orthop. 2015 Oct;39(10 ):2011-6 - PubMed
  3. Am Heart J. 2013 Aug;166(2):325-332.e1 - PubMed
  4. Am J Cardiol. 2015 Jun 15;115(12):1643-8 - PubMed
  5. BMJ. 2014 Aug 12;349:g4829 - PubMed
  6. J Gerontol A Biol Sci Med Sci. 2007 Apr;62(4):420-6 - PubMed
  7. Medicine (Baltimore). 2017 Feb;96(7):e6169 - PubMed
  8. Circulation. 2017 May 16;135(20):1911-1921 - PubMed
  9. Mol Cell Biochem. 2017 Jun;430(1-2):191-199 - PubMed
  10. Scand J Immunol. 2007 Jan;65(1):99-105 - PubMed
  11. J Arthroplasty. 2017 Aug;32(8):2359-2362 - PubMed
  12. Semin Thromb Hemost. 2015 Sep;41(6):615-20 - PubMed
  13. J Gerontol A Biol Sci Med Sci. 2010 Apr;65(4):442-9 - PubMed
  14. Clin Orthop Relat Res. 2009 Apr;467(4):946-51 - PubMed
  15. J Leukoc Biol. 2012 Sep;92(3):539-51 - PubMed
  16. Injury. 2011 Jul;42(7):707-13 - PubMed
  17. Clin Orthop Relat Res. 2008 Nov;466(11):2617-27 - PubMed
  18. Med Sci Monit. 2013 Jan 28;19:73-80 - PubMed
  19. N Engl J Med. 2009 Sep 3;361(10):980-9 - PubMed
  20. Clin Chem. 1997 Sep;43(9):1749-56 - PubMed
  21. Clin Chem. 2009 Nov;55(11):2057-9 - PubMed
  22. Hosp Pract (1995). 2017 Feb;45(1):16-20 - PubMed
  23. JAMA. 2012 Jun 6;307(21):2295-304 - PubMed
  24. N Engl J Med. 2009 Apr 30;360(18):1851-61 - PubMed
  25. Clin Chem. 2012 Nov;58(11):1574-81 - PubMed
  26. Am J Med. 2016 Apr;129(4):354-65 - PubMed
  27. J Thromb Thrombolysis. 2012 May;33(4):371-82 - PubMed
  28. J Bone Joint Surg Br. 2012 Nov;94(11):1557-66 - PubMed
  29. Sci Transl Med. 2014 Sep 24;6(255 ):255ra131 - PubMed
  30. JAMA. 2015 Sep 15;314(11):1159-66 - PubMed
  31. Am J Cardiol. 2014 Jul 15;114(2):193-7 - PubMed
  32. Reg Anesth Pain Med. 2011 Jan-Feb;36(1):36-40 - PubMed
  33. Eur Heart J. 2016 Jan 7;37(2):177-85 - PubMed
  34. J Vasc Surg. 2004 May;39(5):967-75; discussion 975-6 - PubMed
  35. Biochim Biophys Acta. 2011 May;1813(5):878-88 - PubMed
  36. J Immunol. 2005 Sep 15;175(6):3463-8 - PubMed
  37. J Am Coll Cardiol. 2010 Sep 28;56(14):1099-109 - PubMed
  38. J Intern Med. 2010 Aug;268(2):155-61 - PubMed
  39. JAMA Intern Med. 2017 Feb 1;177(2):231-242 - PubMed
  40. Arthritis Rheumatol. 2015 Oct;67(10 ):2771-9 - PubMed
  41. Clin Diagn Lab Immunol. 2004 Mar;11(2):325-9 - PubMed
  42. Lancet. 1994 Nov 19;344(8934):1383-9 - PubMed
  43. Am J Clin Pathol. 2002 Sep;118(3):346-53 - PubMed
  44. BMC Musculoskelet Disord. 2013 Jun 04;14:177 - PubMed
  45. N Engl J Med. 2008 Nov 20;359(21):2195-207 - PubMed
  46. Am Heart J. 2010 Aug;160(2):224-9 - PubMed
  47. Arch Intern Med. 2012 Sep 10;172(16):1229-35 - PubMed
  48. Br J Anaesth. 2016 Nov;117(5):559-568 - PubMed
  49. Arthritis Rheumatol. 2014 Feb;66(2):311-8 - PubMed
  50. Heart. 2016 Apr;102(7):508-17 - PubMed

Publication Types